Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion type Assertion NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_head.
- NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion wasGeneratedBy ECO_0000218 NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_provenance.
- NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion wasDerivedFrom ctd_human-20150221 NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_provenance.
- NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion SIO_000772 19407222 NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_provenance.
- NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion evidence source_evidence_curated NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_provenance.
- NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_assertion description "[Results of the present study indicate that 1) PGE(2) promotes survival of human endometriotic cells through EP2 and EP4 receptors by activating ERK1/2, AKT, nuclear factor-kappaB, and beta-catenin signaling pathways; 2) selective inhibition of EP2 and EP4 suppresses these cell survival pathways and augments interactions between proapoptotic proteins (Bax and Bad) and antiapoptotic proteins (Bcl-2/Bcl-XL), facilitates the release of cytochrome c, and thus activates caspase-3/poly (ADP-ribose) polymerase-mediated intrinsic apoptotic pathways; and 3) these PGE(2) signaling components are more abundantly expressed in ectopic endometriosis tissues compared with eutopic endometrial tissues during the menstrual cycle in women.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27582.RATFnj3TQ8v_9aVzqbGbKj7YO0ejsJEA9wZFZ6BBMvyYI130_provenance.